Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma

Uttervall, K; Bruchfeld, JB; Gran, C; Walinder, G; Mansson, R; Lund, J; Gahrton, G; Alici, E; Nahi, H

Bruchfeld, JB (reprint author), Karolinska Inst, Karolinska Univ Sjukhuset Huddinge, Unit Hematol M 54, Dept Med,Huddinge MedH H7 & Res, S-14186 Stockholm, Sweden.

EUROPEAN JOURNAL OF HAEMATOLOGY, 2019; 103 (3): 247

Abstract

Objectives At our center, patients with multiple myeloma (MM) were treated upfront with bortezomib, cyclophosphamide, and dexamethasone (VCD) until cy......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索